Abstract
Background
The syndrome of heart failure (HF) is characterized by left ventricular dysfunction and a compensatory chronic over activation of the sympathetic nervous system. We wanted to investigate if the beneficial effects of exercise training (ET) in HF patients on optimal medical therapy (OMT) are associated with alterations in cardiac sympathetic activity.
Methods
Cardiac sympathetic activity was evaluated at baseline and after 12 weeks using metaiodobenzylguanidine scintigraphy in 23 patients with stable HF participating in the SmartEx trial. Patients with HF in New York Heart Association class II or III and left ventricular ejection fraction <35 % were randomized to three different ET groups.
Results
We found no statistically significant changes in cardiac sympathetic activity after 12 weeks of ET. Heart to mediastinum (H/M) ratio at 15 minutes (0.00174 ± 0.0841, P = 0.922), H/M ratio at 4 hours (−0.00565 ± 0.1163, P = 0.818) and washout ratio (WR) (−1.2666 ± 16.5412, P = 0.717). A further group-wise analysis of the three ET groups did not show any difference between the groups.
Conclusion
A 12-week ET program did not alter the abnormal cardiac sympathetic activity in stable HF patients on modern OMT.
Similar content being viewed by others
Abbreviations
- HF:
-
Heart failure
- ET:
-
Exercise training
- MIBG:
-
Iodine-123-metaiodobenzylguanidine
- H/M:
-
Heart to mediastinum ratio
- WR:
-
Washout ratio
- LVEF:
-
Left ventricle ejection fraction
- NE:
-
Norepinephrine
- VO2peak :
-
Peak oxygen uptake
- OMT:
-
Optimal medical therapy
References
Hasking GJ, Esler MD, Jennings GL, et al. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615–21. doi:10.1161/01.cir.73.4.615.
Caldwell JH, Caldwell JH, Link JM, et al. Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med. 2008;49:234–41. doi:10.2967/jnumed.107.044339.
Ungerer M, Böhm M, Elce JS, et al. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation. 1993;87:454–63. doi:10.1161/01.cir.87.2.454.
Cohen-Solal A, Esanu Y, Logeart D, et al. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol. 1999;33:759–66. doi:10.1016/S0735-1097(98)00608-1.
Jacobson AF, Senior R, Cerqueira MD, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. J Am Coll Cardiol. 2010;55:2212–21. doi:10.1016/j.jacc.2010.01.014.
Merlet P, Valette H, Dubois-Randé JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471–7.
Hasking GJ, Esler MD, Jennings GL, et al. Norepinephrine spillover to plasma during steady-state supine bicycle exercise. Comparison of patients with congestive heart failure and normal subjects. Circulation. 1988;78:516–21. doi:10.1161/01.cir.78.3.516.
Sato M, Maehara K, Yaoita H, et al. Correlation between cardiac norepinephrine overflow during exercise and cardiac 123I-MIBG uptake in patients with chronic heart failure. J Nucl Med. 2003;44:1618–24.
Agostini D, Lecluse E, Belin A, et al. Impact of exercise rehabilitation on cardiac neuronal function in heart failure: An iodine-123 metaiodobenzylguanidine scintigraphy study. Eur J Nucl Med. 1998;25:235–41. doi:10.1007/s002590050222.
Schofer J, Spielmann R, Schuchert A, et al. Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1988;12:1252–8. doi:10.1016/0735-1097(88)92608-3.
Chizzola PR, Gonçalves de Freitas HF, Marinho NVS, et al. The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure. Int J Cardiol. 2006;106:29–34. doi:10.1016/j.ijcard.2004.12.050.
McMurray JJV, Adamopoulos S, Anker A-BSD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69. doi:10.1093/eurjhf/hfs105.
Stoylen A, Conraads VM, Halle M, et al. Controlled study of myocardial recovery after interval training in heart failure: SMARTEX-HF-rationale and design. Eur J Prev Cardiol. 2012;19:813–21. doi:10.1177/1741826711403252.
Haykowsky MJ, Liang Y, Pechter D, et al. A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: The benefit depends on the type of training performed. J Am Coll Cardiol. 2007;49:2329–36. doi:10.1016/j.jacc.2007.02.055.
Veltman CE, Boogers MJ, Meinardi JE, et al. Reproducibility of planar 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging. 2012;39:1599–608. doi:10.1007/s00259-012-2180-2.
Jacobson AF, Lombard J, Banerjee G, Camici PG. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials. J Nucl Cardiol. 2008;16:113–21. doi:10.1007/s12350-008-9008-2.
Murad K, Brubaker PH, Fitzgerald DM, et al. Exercise training improves heart rate variability in older patients with heart failure: A randomized, controlled, single-blinded trial. Congest Heart Fail. 2012;18:192–7. doi:10.1111/j.1751-7133.2011.00282.x.
Munk PS, Butt N, Larsen AI. High-intensity interval exercise training improves heart rate variability in patients following percutaneous coronary intervention for angina pectoris. Int J Cardiol. 2010;145:312–4. doi:10.1016/j.ijcard.2009.11.015.
Larsen AI, Gjesdal K, Hall C, Aukrust PP. Effect of exercise training in patients with heart failure: A pilot study on autonomic balance assessed by heart rate variability. Eur J Prev Cardiol. 2004;11:162–7. doi:10.1097/01.hjr.0000124214.21584.bb.
Agostini D, Belin A, Amar MH, et al. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: A 123I-MIBG scintigraphic study. J Nucl Med. 2000;41:845–51.
Cohen-Solal A, Rouzet F, Berdeaux A, et al. Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure. J Nucl Med Off Publ Soc Nucl Med. 2005;46:1796–803.
Takeishi Y, Atsumi H, Fujiwara S, et al. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med Off Publ Soc Nucl Med. 1997;38:1085–9.
Kasama S, Toyama T, Kumakura H, et al. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2003;41:574–81. doi:10.1016/s0735-1097(02)02855-3.
Floras JS, Ponikowski P. The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction. Eur Heart J. 2015;36:1974–82. doi:10.1093/eurheartj/ehv087.
Gao J, Zucker IH, Gao L. Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure. Am J Hypertens. 2014;27:1248–56. doi:10.1093/ajh/hpu044.
Verberne HJ, Verberne HJ, Brewster LM, et al. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: A systematic review. Eur Heart J. 2008;29:1147–59. doi:10.1093/eurheartj/ehn113.
McMurray JJV, Adamopoulos S, Anker A-BSD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–847. doi:10.1093/eurheartj/ehs104.
Acknowledgements
Stavanger Health Research: Åse Marit Brøndbo, Anne Haugland, and Marit Kristiansen for their help and contributions during exercise training. Jorunn Nilsen for coordinating, testing, and helping with examinations. Torbjørn Aarsland for CPET examinations. The staff at the Department of Nuclear Imaging, Stavanger University Hospital: Randi Ursin, Jan Erik Berge, Azora Marie Ramsvik, and Hilde Ødegård. Stavanger University: Jan Terje Kvaløy and Lena Bache-Mathiesen for statistical advice. Camilla Normand for linguistic advice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Torstein Valborgland, Kjetil Isaksen, Peter Scott Munk, Zbigniew Piotr Grabowski and Alf Inge Larsen have no conflict of interest.
Additional information
Clinical trial registration information: a sub study of the SmartEx trial: Clinical trials.gov NCT00917046, https://clinicaltrials.gov/ct2/show/NCT00917046
Funding: This work was supported by Western Norway Regional Health Authority [Grant Number 911 715].
Rights and permissions
About this article
Cite this article
Valborgland, T., Isaksen, K., Munk, P.S. et al. Impact of an exercise training program on cardiac neuronal function in heart failure patients on optimal medical therapy. J. Nucl. Cardiol. 25, 1164–1171 (2018). https://doi.org/10.1007/s12350-016-0724-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-016-0724-8